Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod.

Front Immunol · 2024 · PMC11116603 · PMID 38799457

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In addition, serum B-cell, lymphocyte, and immunoglobulin levels showed a decreasing trend ( Figure 3 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.